| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 08/20/2002 | US6436965 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
| 08/20/2002 | US6436952 Cyclic nucleotide phosphodiesterase inhibitors; inflammatory airway disorders, such as asthma; antiinflammatory; 6-(4-(2h-2-ethyltetrazol-5-yl) phenyl)-1,2,3,4,4a,10b-hexahydrobenzo(c)(1,6)naohthyridine n-2-oxides |
| 08/20/2002 | US6436942 Enantiomers of 1[(4-chloro-phenyl) phenylmethyl]-4-[(4-methylphenyl) sulfony]piperazine |
| 08/20/2002 | US6436924 Useful for treating allergic rhinitis, vasomotor rhinitis and allergic conjunctivitis; nonsedating antihistamines or salts, leukotriene d4 antagonist or 5-lipoxygenase inhibitor or flap protein antagonist |
| 08/20/2002 | US6436909 Antisense inhibition of transforming growth factor-β expression |
| 08/20/2002 | US6436905 Lipid-containing compositions and uses thereof |
| 08/20/2002 | US6436390 IL8 inhibitors |
| 08/20/2002 | CA2266183C Herbal composition for treatment of bronchitis and respiratory disorders with anti cancer properties and process for preparing same |
| 08/20/2002 | CA2073983C Novel vitamin d analogues |
| 08/20/2002 | CA2052041C Benzimidazole derivatives, their preparation and use |
| 08/15/2002 | WO2002063006A2 Receptors and membrane-associated proteins |
| 08/15/2002 | WO2002062945A2 Compositions and methods relating to lung specific genes and proteins |
| 08/15/2002 | WO2002062816A1 Non-natural nucleotides and dinucleotides |
| 08/15/2002 | WO2002062804A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 08/15/2002 | WO2002062801A1 Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, medicinal compositions, adenosine a3 receptor affinity agents, ocular tension lowering agents, preparations for preventing and treating glaucoma and method of lowering ocular tension |
| 08/15/2002 | WO2002062800A1 Bicyclic nitrogenous fused-ring compound |
| 08/15/2002 | WO2002062793A1 Thiazole compounds as tgf-beta inhibitors |
| 08/15/2002 | WO2002062792A1 Jnk inhibitor |
| 08/15/2002 | WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/15/2002 | WO2002062788A1 Sulfonamide compounds, their preparation and use |
| 08/15/2002 | WO2002062787A1 Pyrazoles as tgf inhibitors |
| 08/15/2002 | WO2002062785A1 Benzimidazole derivatives, method for their production and use thereof as tryptase inhibitors |
| 08/15/2002 | WO2002062784A1 Piperidinee derivatives as neurokinin 1 antagonists |
| 08/15/2002 | WO2002062778A2 Anti-thrombotic compounds, production and use thereof as medicaments |
| 08/15/2002 | WO2002062776A1 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors |
| 08/15/2002 | WO2002062762A2 Potassium channel openers |
| 08/15/2002 | WO2002062761A1 Aminal diones as potassium channel openers |
| 08/15/2002 | WO2002062751A1 Novel cystine derivatives and inhibitors for the activation of inflammatory factors |
| 08/15/2002 | WO2002062750A1 Cannabinoid receptor ligands |
| 08/15/2002 | WO2002062748A1 Carboxylic amides, the production and use thereof as medicaments |
| 08/15/2002 | WO2002062745A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity |
| 08/15/2002 | WO2002062343A2 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO[4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS |
| 08/15/2002 | WO2002062337A1 Thiazolidinediones |
| 08/15/2002 | WO2002062317A2 Bimodal dry powder formulation for inhalation |
| 08/15/2002 | WO2002050101A8 Retinoblastoma-binding protein |
| 08/15/2002 | WO2002034753A3 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 08/15/2002 | WO2002028866A3 Hydroxyesters of 7-desmethylrapamycin |
| 08/15/2002 | WO2002028434A3 Use of a ppar delta activator for treating inflammatory conditions |
| 08/15/2002 | WO2002028433A3 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition |
| 08/15/2002 | WO2002022212A8 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 08/15/2002 | WO2001032877A9 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 08/15/2002 | WO2001027135A9 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 08/15/2002 | US20020111505 Purified 15-epi-lipoxin compound has a longer tissue half-life; anticancer agents |
| 08/15/2002 | US20020111493 Amidino compounds useful as nitric oxide synthase inhibitors |
| 08/15/2002 | US20020111378 Inhibitors of IMPDH enzyme |
| 08/15/2002 | US20020111359 Side effect reduction of narcotics |
| 08/15/2002 | US20020111356 Phosphodiesterase inhibitor; antiinflammatory agents |
| 08/15/2002 | US20020111353 Antiinflammatory agents; central nervous system disorders;antidiabgetic agents; rheumatic disorders |
| 08/15/2002 | US20020111351 New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation |
| 08/15/2002 | US20020111333 Hypotensive agents; cardiovascular disorders |
| 08/15/2002 | US20020111306 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 08/15/2002 | US20020110858 Lymphocytic membrane proteins |
| 08/15/2002 | US20020110836 PD-L2 molecules: novel PD-1 ligands and uses therefor |
| 08/15/2002 | US20020110529 Inhalable powder containing tiotropium |
| 08/15/2002 | US20020110524 Method for stabilizing biomolecules in liquid formulations |
| 08/15/2002 | US20020109025 Generating fine medicament powders suitable for inhalation using a fluid energy milling with milling fluid such as air or nitrogen at a controlled relative humidity 30-50%; triamcinolone acetonide or salbutamol sulfate |
| 08/15/2002 | CA2437571A1 Receptors and membrane-associated proteins |
| 08/15/2002 | CA2437437A1 Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, pharmaceutical, composition adenosine a3 receptor affinitive agent, intraocular-pressure reducing agent, pharmaceutical preparation for prevention and treatment of glaucoma, and intraocular-pressure reducing method |
| 08/15/2002 | CA2437405A1 Potassium channel openers |
| 08/15/2002 | CA2437400A1 Aminal diones as potassium channel openers |
| 08/15/2002 | CA2437260A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 08/15/2002 | CA2437248A1 Jnk inhibitor |
| 08/15/2002 | CA2437085A1 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidines and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists |
| 08/15/2002 | CA2436837A1 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions |
| 08/15/2002 | CA2435982A1 Medicaments |
| 08/15/2002 | CA2435492A1 Antithrombotic compounds, the preparation thereof and their use as pharmaceutical compositions |
| 08/14/2002 | EP1231270A1 Novel protein and dna thereof |
| 08/14/2002 | EP1230929A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
| 08/14/2002 | EP1230367A1 19 human secreted proteins |
| 08/14/2002 | EP1230360A2 15 human secreted proteins |
| 08/14/2002 | EP1230243A1 Poycyloalkylpurines as adenosine receptor antagonists |
| 08/14/2002 | EP1230241A2 Adenosine receptor antagonists and methods of making and using the same |
| 08/14/2002 | EP1230236A1 Compound with growth hormone releasing properties |
| 08/14/2002 | EP1230227A1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 08/14/2002 | EP1230222A1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 08/14/2002 | EP1230215A1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 08/14/2002 | EP1230214A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 08/14/2002 | EP1229954A1 Method of treating cardio pulmonary diseases with no group compounds |
| 08/14/2002 | EP1229931A1 Fusion proteins of mycobacterium tuberculosis |
| 08/14/2002 | EP1229930A1 Compositions and methods for treatment of allergic disorders |
| 08/14/2002 | EP1014993B1 New use for budesonide and formoterol |
| 08/14/2002 | EP0937076B1 Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 08/14/2002 | EP0892642B1 Use in a composition of an extract of at least one labiate of the genus rosmarinarus, cultured in vitro |
| 08/14/2002 | EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
| 08/14/2002 | CN1364155A N-Cyanomethyl amides as protease inhibitors |
| 08/14/2002 | CN1364085A Use of phyllanthus for treating chronically inflammatory and fibrotic processes |
| 08/14/2002 | CN1364075A Ambroxol-containing lozenge |
| 08/14/2002 | CN1363383A Inhalation 'Shangfengjing' and its preparing process |
| 08/14/2002 | CN1363366A Antivirus defervescent |
| 08/14/2002 | CN1363352A Chuqin Zihou San and its preparing process |
| 08/14/2002 | CN1363330A Nano medicine 'Qingqi Huatan' and its preparing process |
| 08/14/2002 | CN1363325A Nano medicine 'Zhongganling' and its preparing process |
| 08/14/2002 | CN1363322A Nano medicine 'Yinhuang' and its preparing process |
| 08/14/2002 | CN1363310A Nano medicine 'Juhong Tanke' and its preparing process |
| 08/14/2002 | CN1363304A Nano medicine for strengthening patient's resistance and nourishing essence and its preparing process |
| 08/14/2002 | CN1363303A Nano medicine 'Compound Sanju' for treating cold and its preparing process |
| 08/14/2002 | CN1363300A Nano medicine 'Erchen Wan' and its preparing process |
| 08/14/2002 | CN1363293A Nano medicine for treating baby cough and its preparing process |
| 08/14/2002 | CN1363283A Beetoxin injection and its preparing process |
| 08/14/2002 | CN1089004C Dressing for treating infantile bronchitis and pulmonitis and its preparation |